About

Dr. Andermann’s research focus on how intestinal microbiome-host interactions impact infectious complications and other outcomes in patients with hematologic malignancies. Her goal is to develop microbiome-targeted therapies for the prevention and treatment of infectious diseases in these and other immunocompromised patient populations.

I am an Infectious Diseases physician specializing in the care of patients with compromised immune systems. I work together with a team of physicians and health professionals to provide the best and most compassionate care possible to those patients with cancer or who have undergone transplantation.